Heavy/light chain ratio normalization prior to transplant is of independent prognostic significance in multiple myeloma: A BMT CTN 0102 correlative study

Lignende værker

• Tandem Autologous-Autologous versus Autologous-Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Multiple Myeloma: Long-term Follow-Up Results from the Blood and Marrow Transplant Clinical Trials Network (BMT CTN) 0102 Trial.
  af: Giralt, Sergio, et al.
  Udgivet: (2019)
• Tandem Autologous versus Single Autologous Transplantation Followed by Allogeneic Hematopoietic Cell Transplantation for Patients with Multiple Myeloma: Results from the Blood and Marrow Transplant Clinical Trials Network (BMT CTN) 0102 Trial
  af: Krishnan, Amrita, et al.
  Udgivet: (2011)
• Autologous Transplantation, Consolidation, and Maintenance Therapy in Multiple Myeloma: Results of the BMT CTN 0702 Trial
  af: Stadtmauer, Edward A., et al.
  Udgivet: (2019)
• Summary of the Third Annual BMT CTN Myeloma Intergroup Workshop on Minimal Residual Disease and Immune Profiling
  af: Holstein, Sarah A., et al.
  Udgivet: (2019)
• Low EGF in Myeloablative Allotransplantation: Association with Severe Acute GVHD in BMT CTN 0402
  af: Holtan, Shernan G., et al.
  Udgivet: (2017)